Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Rexahn
Rexahn
Rexahn Pharmaceuticals Terminates Breast Cancer Study with Merck
BioSpace
Thu, 04/9/20 - 11:18 pm
Rexahn
triple negative breast cancer
Merck
Keytruda
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Tue, 10/4/16 - 10:07 am
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
Rexahn's Human Data Confirms Anti-Cancer Advantage
Yahoo
Wed, 09/30/15 - 09:41 am
Rexahn
RX-3117
Supinoxin
cancer
Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off
Seeking Alpha
Tue, 01/13/15 - 04:28 pm
Rexahn
RX-3117
Eli Lilly
Gemzar
solid tumors
Rexahn Pharmaceuticals Provides Update on Phase I Supinoxin Trial in Cancer Patients with Solid Tumors
Pharmiweb
Sat, 07/19/14 - 09:05 am
Supinoxin
Rexahn
Think Like a Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives on Six Exciting Biotechs
IT Business Net
Sat, 05/17/14 - 10:38 am
Opexa
Biocryst
Rexahn
Corcept Therapeutics
Ligand Pharmaceuticals
MannKind
Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff
Seeking Alpha
Mon, 04/21/14 - 04:46 pm
Taxotere
Rexahn
RX-21101
patents
patent cliff
Bristol-Myers Squibb
Roche
Sanofi
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013
TheStreet.com
Tue, 01/21/14 - 09:37 am
biotech
Intercept Pharma
Rexahn
CorMedix
Neurocrine
Cell Therapeutics
3 Biotechs Getting Plenty Of Attention From Investors
Seeking Alpha
Wed, 01/15/14 - 10:09 am
Depomed
Rexahn
Cambia
Zipsor
Gralise
Cangene
Emergent BioSolutions
Why Rexahn Pharmaceuticals (RNN) Is Up Today
TheStreet.com
Fri, 01/10/14 - 10:56 am
Rexahn
Archexin
Supinoxin
RX-3117
Rexahn: A Turn Around Story For 2014
Seeking Alpha
Mon, 12/23/13 - 09:59 am
Rexahn
oncology
Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill
Seeking Alpha
Mon, 10/7/13 - 08:48 am
Rexahn
chemotherapy
Amgen
Bristol-Myers Squibb
Merck
Novartis
Teva
RX-3117
Rexahn Regains Rights To Novel Cancer Drug As Teva Continues Its Pipeline Stumble
Seeking Alpha
Fri, 09/6/13 - 10:31 am
Teva
Rexahn
RX-3117
Teva-Rexahn Deal Terminated - Analyst Blog
NASDAQ
Sat, 08/31/13 - 11:59 am
Teva
Rexahn
RX-3117
Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
Seeking Alpha
Tue, 08/6/13 - 10:49 am
Rexahn
Merck
Novo Nordisk
Teva
Archexin
cancer
Rexahn awarded U.S. patent for novel anti-cancer compounds
Yahoo/Fly on the Wall
Mon, 06/17/13 - 09:49 am
patents
Rexahn
quinazoline
anti-tumor
Rexahn says to continue RX-3117 development with Teva
The Fly on the Wall
Tue, 02/19/13 - 10:07 am
Rexahn
RX-3117
Teva
RX-5902
Archexin
Rexahn Pharmaceuticals: Update On Cancer Drugs
Seeking Alpha
Fri, 05/18/12 - 11:00 am
Teva Pharmaceuticals
Rexahn
Archexin
RX-3117
RX-5902
RX-8243
cancer
akt protein inhibitor
You Should Have Seen These Biotech Failures Coming
Motley Fool
Sat, 11/5/11 - 02:44 pm
Oxigene
Rexahn
Rexahn Pharmaceuticals advances pancreatic cancer drug
Bizjournals.com
Wed, 09/28/11 - 12:31 pm
Rexahn
pancreatic cancer
Pages
1
2
next ›
last »